AmerisourceBergen Enhances Global Market Position through European Acquisition

AmerisourceBergen Enhances Global Market Position through European Acquisition

A Leading European Market Access Consulting Company, Herescon, Joins AmerisourceBergen under Xcenda

Palm Harbor, FL., March 4, 2014 – Xcenda, an AmerisourceBergen company (NYSE: ABC), has acquired Herescon, a leading research and consulting firm based in Hannover, Germany.  This acquisition expands the global business presence for Xcenda and AmerisourceBergen Consulting Services.

The addition of Herescon to the Xcenda team enables the company to more fully address the global biopharmaceutical industry's growing demand for health technology assessment, market access strategy, scientific communications, and related commercialization services.  Customers of both Herescon and Xcenda will benefit from the combined expertise of strategic consultants, economists, pharmacists and clinicians, all of whom have substantial healthcare research experience.  Xcenda's market position is further enhanced by adding expertise in the European market, providing customers with greater access to direct visibility into European developments and regulatory topics, and bringing a strong local presence of market access consultants and research analysts.  In addition, Herescon's reach in Europe helps establish a platform for future global growth and expansion for the combined entity. 

"I am excited to join the leadership team at Xcenda," said Dr. Thomas Mittendorf, Managing Director of Herescon.  "We are pleased to combine our market access and research expertise in Europe with Xcenda's broad and strategic consulting expertise across the pharmaceutical lifecycle.  I can speak for the entire Herescon team when I say that everyone is eager to begin collaborating with our new colleagues."

"The combined knowledge and reach of our team provides a significant enhancement to how and where we serve customers," said Dr. Brian Nightengale, President of Xcenda.  "Adding the Herescon team strengthens our commitment to shaping healthcare delivery and I am very excited that Thomas and his team are now part of the Xcenda organization.

About AmerisourceBergen

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel. With over $100 billion in annualized revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 13,000 people. AmerisourceBergen is ranked #32 on the Fortune 500 list. For more information, go

About Xcenda, LLC

Xcenda, a part of the AmerisourceBergen Corporation, is a strategic consulting firm with 20 years of experience applying real-world expertise in health economics and outcomes research, reimbursement, health policy, market research, and market access strategy. From development through market maturity, Xcenda helps manufacturers identify, demonstrate, and deliver their brand's value proposition to key healthcare stakeholders. Xcenda is backed by an even wider breadth of healthcare knowledge and partnerships through AmerisourceBergen, one of the world's largest pharmaceutical services companies.

About Herescon GmbH

Herescon is a scientific contract research and consulting institute for healthcare related studies. The company specializes in the benefit analysis of pharmaceuticals, market access services, pricing and reimbursement, analysis of primary and secondary research data, health services research, health economic evaluation as well as scientific communication.  Located in Hannover, Germany, Herescon provides services across the European marketplace.  For more information, go to